伐谋-中小盘信息更新 三夫户外（002780.SZ） 品牌化运营元年，全渠道布局成效初显 2025 年 04 月 30 日 投资评级：买入（维持） | 日期 | 2025/4/29 | | --- | --- | | 当前股价(元) | 12.28 | | 一年最高最低(元) | 16.00/8.20 | | 总市值(亿元) | 19.35 | | 流通市值(亿元) | 16.04 | | 总股本(亿股) | 1.58 | | 流通股本(亿股) | 1.31 | | 近 3 个月换手率(%) | 392.85 | 中小盘研究团队 ——中小盘信息更新 | 周佳（分析师） | 张越（分析师） | 赵晨旭（联系人） | | --- | --- | --- | | zhoujia@kysec.cn | zhangyue1@kysec.cn | zhaochenxu@kysec.cn | | 证书编号：S0790523070004 | 证书编号：S0790524090003 | 证书编号：S0790124120019 | 聚焦品牌运营，2025Q1 经营业绩超预期 公司发布 2024 年年报及 2025 年一季报，20 ...

医药生物 | 证券研究报告 — 调整盈利预测 2025 年 4 月 30 日 688085.SH 买入 原评级：买入 市场价格:人民币 17.47 板块评级:强于大市 股价表现 (%) 今年 至今 1 个月 3 个月 12 个月 绝对 (13.8) (3.5) (6.7) (7.1) 相对上证综指 (14.6) (1.6) (7.8) (12.7) 发行股数 (百万) 277.89 流通股 (百万) 248.45 总市值 (人民币 百万) 4,854.66 3 个月日均交易额 (人民币 百万) 35.04 主要股东 QM5 LIMITED 14.74 (19%) (10%) (2%) 7% 15% 24% Apr-24 Jun-24 Jul-24 Aug-24 Sep-24 Oct-24 Nov-24 Dec-24 Jan-25 Feb-25 Mar-25 Apr-25 三友医疗 上证综指 资料来源：公司公告， Wind ，中银证券 以 2025 年 4 月 29 日收市价为标准 相关研究报告 《三友医疗》20241105 《三友医疗》20240829 《三友医疗》20240816 中银国际证券股份有限公司 ...

Investment Rating - The report maintains a "Strong Buy" rating for the company [2][5]. Core Views - The company reported a robust growth in Q1 2025, achieving a revenue of 4.299 billion yuan, a year-on-year increase of 22.98%, and a net profit of 465 million yuan, up 67.85% year-on-year [3]. - The core business segments showed strong performance, particularly the functional products segment, which saw a revenue increase of 29% to 3.319 billion yuan, driven by excellent performance in methionine and vitamin businesses [3]. - The company is expanding its methionine production capacity to solidify its leading position in the industry, with ongoing investments in its production platforms in Europe and Nanjing, China [4]. Financial Performance Summary - The company is projected to maintain its profit forecasts for 2025-2027, with net profits expected to be 1.637 billion yuan, 1.852 billion yuan, and 2.025 billion yuan respectively, corresponding to EPS of 0.61, 0.69, and 0.75 yuan [5][10]. - The current P/E ratios for 2025, 2026, and 2027 are projected to be 16, 14, and 13 times respectively [5]. Production Capacity Expansion - The company has two methionine production platforms, with a total annual capacity increase of 80,000 tons in Europe and 180,000 tons in Nanjing, China [4]. - A new solid methionine plant with an annual capacity of 150,000 tons is under construction in Quanzhou, expected to be operational by 2027 [4]. Market Position - The company is recognized as a leading player in the global animal nutrition industry and is the second-largest methionine producer worldwide, capable of producing both solid and liquid methionine [6].

Investment Rating - The report maintains a "Strong Buy" rating for Lier Chemical [2][4]. Core Views - Lier Chemical reported a significant year-on-year revenue growth of 49.99% in Q1 2025, reaching 2.086 billion yuan, and a net profit increase of 219.90%, amounting to 153 million yuan [3]. - The growth in performance is attributed to the rise in sales and prices of certain products, although the core product, glyphosate, remains at a low price level, awaiting recovery [3]. - The agricultural pesticide industry is currently at the bottom of its cycle, with increased competition and an oversupply situation due to new production capacities and inventory buildup [3]. - Positive factors for the industry's healthy development are gradually increasing, with some product prices rising, but competition remains fierce for certain pesticide products [3]. - The report anticipates that after a period of capacity optimization and consolidation, companies without competitive advantages will exit the market, leading to increased industry concentration [3]. - Lier Chemical is well-positioned in the glyphosate market, with a broad demand space and strategic partnerships with multinational companies for the promotion of refined glyphosate products [4]. Financial Forecasts - The net profit forecasts for Lier Chemical from 2025 to 2027 are 429 million yuan, 591 million yuan, and 766 million yuan, respectively, with corresponding EPS of 0.54 yuan, 0.74 yuan, and 0.96 yuan [4][6]. - The current P/E ratios for the years 2025, 2026, and 2027 are projected to be 19, 14, and 11 times, respectively [4].

投资评级：买入（维持） | 日期 | 2025/4/29 | | --- | --- | | 当前股价(元) | 63.86 | | 一年最高最低(元) | 77.65/35.74 | | 总市值(亿元) | 73.12 | | 流通市值(亿元) | 47.30 | | 总股本(亿股) | 1.15 | | 流通股本(亿股) | 0.74 | | 近 3 个月换手率(%) | 202.39 | 中小盘研究团队 ——中小盘信息更新 | 周佳（分析师） | 孟鹏飞（分析师） | 赵晨旭（联系人） | | --- | --- | --- | | zhoujia@kysec.cn | mengpengfei@kysec.cn | zhaochenxu@kysec.cn | | 证书编号：S0790523070004 | 证书编号：S0790522060001 | 证书编号：S0790124120019 | 下游需求持续增长，经营业绩稳步提升 伐谋-中小盘信息更新 日联科技（688531.SH） 经营业绩稳健增长，核心部件国产替代加速 2025 年 04 月 30 日 公司发布 2024 年年报及 2025 年一季报， ...

2025 年 04 月 30 日 小熊电器(002959.SZ) Q1 收入延续良好增长趋势 事件：小熊电器公布公布 2025 年一季度报告。公司 2025Q1 实 现收入 13.2 亿元，YoY+10.6%；实现归母净利润 1.3 亿元，YoY- 14.0%。展望后续，随着公司不断拓展新品类，持续发力海外市场， 收入有望保持增长趋势。 Q1 收入增长趋势良好：国内家电以旧换新政策拉动厨房小家电 行业需求。根据久谦，Q1 小熊线上销售额 YoY+22%。从品类来看， Q1 小熊线上咖啡机、豆浆机、破壁机等品类销售额实现快速增长。 展望后续，以旧换新有望带动公司内销业务保持良好增长趋势。 另一方面，公司持续提升海外产品研发和策划能力，积极拓展海 外渠道。海外业务有望持续贡献增长动力。此外，2024 年 7 月公 司并表罗曼智能，为公司收入带来增量。 Q1 盈利能力同比下降：Q1 公司毛销差同比+0.9pct，我们认为 主要因为以旧换新带动产品均价提升。Q1 公司归母净利率同比- 2.8pct。Q1 公司净利率下降的主要原因包括：1）公司研发和管理 费用支出有所增加。Q1 研发/管理费用率分别同比+0.7 pct ...

Investment Rating - The investment rating for the company is "Buy-A" with a 6-month target price of 17.28 CNY, compared to the current stock price of 15.63 CNY as of April 29, 2025 [5]. Core Views - The company reported a significant decline in revenue and net profit for 2024, with revenue at 3.377 billion CNY, down 40.76% year-on-year, and net profit at 492 million CNY, down 56.03% year-on-year. The first quarter of 2025 also showed a decline in revenue to 663 million CNY, down 56.30% year-on-year, and net profit at 57 million CNY, down 77.62% year-on-year [1][2]. - The company is undergoing a strategic transformation as part of its "Six Five Plan," focusing on optimizing its business model, channels, and strategies to enhance long-term competitiveness. There are signs of improvement in Q1 2025 performance compared to the previous quarter [1][2]. - The company is committed to its unique research and development path, focusing on pediatric, adult digestive, and gynecological treatments, with nearly 40 drug candidates in development as of the end of 2024 [3]. Financial Performance Summary - In 2024, the company's gross margin was 44.89%, down 11.40 percentage points year-on-year, while the net margin was 14.89%, down 5.55 percentage points year-on-year. The decline in net margin was less severe than that of gross margin due to effective cost control [2]. - For Q1 2025, the gross margin improved to 37.29%, up 45.49 percentage points quarter-on-quarter, and the net margin improved to 8.87%, up 33.93 percentage points quarter-on-quarter [2]. - The company expects revenue growth rates of 4.6%, 15.2%, and 19.0% for 2025, 2026, and 2027, respectively, with net profit growth rates of 2.5%, 31.6%, and 34.1% for the same years [8].

2025 年 04 月 30 日 赵旭东 H70556@capital.com.tw 目标价(元) 164 公司基本信息 | 产业别 | | 机械设备 | | --- | --- | --- | | A 股价(2025/4/29) | | 140.63 | | 上证指数(2025/4/29) | | 3286.65 | | 股价 12 个月高/低 | | 192.8/58.22 | | 总发行股数(百万) | | 183.21 | | A 股数(百万) | | 168.76 | | A 市值(亿元) | | 237.33 | | 主要股东 | | 左晶(18.80%) | | 每股净值(元) | | 18.81 | | 股价/账面净值 | | 7.48 | | | 一个月 三个月 | 一年 | | 股价涨跌(%) | -5.7 -20.3 | 17.9 | 近期评等 | 出刊日期 | 前日收盘 | 评等 | | --- | --- | --- | | 2024-12-04 | 124.1 | 买进 | 产品组合 | 谐波减速器及金属部件 | 84.0% | | --- | --- | | 机电一体化产品 | ...

公司点评报告 · 通信行业 智算布局突破、创新驱动高质量发展 科华数据 2024 年报点评 2025 年 04 月 28 日 核心观点 科华数据(股票代码:002335) | | | 分析师 赵良毕 ☎：010-8092-7619 网: zhaoliangbi_yj@chinastock.com.cn 分析师登记编码:S0130522030003 曾韬 ☎: 010-8092-7653 0:zengtao_yj@chinastock.com.cn 分析师登记编码：S0130525030001 | 市场数据 | 2024-04-28 | | --- | --- | | 股票代码 | 002335 | | A 股收盘价(元) | 40.97 | | 上证指数 | 3288.41 | | 总股本(万股) | 51541.40 | | 实际流通 A 股(万股) | 45467.26 | | 流通 A 股市值(亿元) | 211.17 | 相对沪深 300 表现图 2024-04-28 资料来源:Wind,中国银河证券研究院 | | 2024A | 2025E | 2026E | 2027E | | --- | --- ...

Investment Rating - The report maintains a "Buy" rating for the company, indicating an expectation that the stock will outperform the market index by more than 15% in the next six months [5][7]. Core Insights - The company's energy storage business continues to show strong growth, contributing significantly to overall profitability stability. The revenue for 2024 is projected at 486.15 billion yuan, with a slight year-on-year decline of 0.35%, while the net profit attributable to shareholders is expected to reach 40.76 billion yuan, reflecting a year-on-year increase of 0.63% [4][5]. - The first quarter of 2025 shows rapid revenue growth, with a total of 127.96 billion yuan, marking a year-on-year increase of 37.34%. The net profit attributable to shareholders for this period is projected at 11.01 billion yuan, up 3.32% year-on-year [4][5]. Summary by Sections Financial Performance - In 2024, the company achieved a revenue of 486.15 billion yuan, with a net profit of 40.76 billion yuan, and a non-recurring net profit of 31.62 billion yuan, which is a 14.76% increase year-on-year. The gross margin was 17.41%, up 0.37 percentage points, while the net margin was 8.68%, down 0.59 percentage points [4][6]. - For Q1 2025, the company reported a revenue of 127.96 billion yuan, a 37.34% increase year-on-year, with a net profit of 11.01 billion yuan, reflecting a 3.32% increase. The non-recurring net profit for this quarter was 8.18 billion yuan, up 16.6% year-on-year [4][6]. Business Segments - The energy storage battery segment generated revenue of 190.3 billion yuan in 2024, a 16.4% increase, accounting for 39% of total revenue. The company’s core product, the Mr.Big series 600Ah+ energy storage cell, is recognized as a technical benchmark in the industry. The energy storage battery shipment volume reached 50.45 GWh in 2024, a 91.9% increase year-on-year [4][5]. - The power battery segment reported a revenue of 191.7 billion yuan in 2024, a 20% decrease, while the shipment volume increased by 7.9% to 30.3 GWh. In Q1 2025, the shipment volume surged to 10.17 GWh, a 57.58% increase year-on-year [4][5]. - The consumer battery segment achieved a revenue of 103.2 billion yuan in 2024, a 23.4% increase, benefiting from the recovery in the consumer electronics market [4][5].